A Phase IV Acceptability and Feasibility Trial of the Effects of Medication on Memory in Idiopathic Nondementing Parkinson's Disease.
Phase of Trial: Phase IV
Latest Information Update: 21 Nov 2018
At a glance
- Drugs Pramipexole (Primary) ; Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Pharmacodynamics
- Acronyms MeMory PaD
- 14 Nov 2018 Status has been changed to discontinued.
- 23 Apr 2015 Accrual to Date is 100% according to the United Kingdom Clinical Research Network record
- 04 Sep 2014 Accrual to Date is 44% according to the United Kingdom Clinical Research Network record.